A Gaucher Disease Gene Therapy Trial With FLT201

Clinical trial NCT07223944 · RECRUITING

Trial details

NCT number: NCT07223944
Sponsor: Spur Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease Type 1

Start date: 2026-04-07
Primary completion: 2028-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.